EASD 2020

Virtual Meeting, 21. – 25. September

Industry Programme

Download Industry Programme 2019


Introducing the
Congress

The EASD Annual Meeting is Europe’s largest and most prominent meeting on diabetes.
The 56th EASD Annual Meeting is transferred into a virtual event, providing a completely new experience and a totally different way to participate. The schedule will remain under the same timeframe and full details of the format will be announced as soon as possible. In the meantime, please refer to the information provided on the official EASD website
and in the EASD 2020 Virtual Meeting FAQ.
The 56th Annual Meeting will be held 21 - 25 September 2020
‍

Meet the Speakers from EASD 2020

Elisabeth Björk
David Cherney
Martin Haluzik
Rolf Hinzmann
Matthias Blüher
H. Wiggers
James Burton
Stephen Nicholls
Ali Dianaty
Naresh Kanumilli
All Speakers

Industry Symposia
Programme at EASD 2020

Monday
Tuesday
Wednesday
Thursday
Friday
09.00 - 16.15
Graz
Beyond the old paradigms: Towards precise solutions in diabetes management
10.30 - 12.00
Villach
TRANSLATING CLINICAL EVIDENCE for SENSOR-BASED GLUCOSE MONITORING and TECHNOLOGICAL INNOVATIONS to the FRONT LINES OF DIABETES PRACTICE
Tadej Battelino
12.00 - 14.00
Linz
Bridging the gap between knowledge and action with SGLT2 inhibitors
Kamlesh Khunti (UK)
Silvio Inzucchi (USA)
Paola Fioretto (Italy)
Mark Petrie (UK) and Simon Moore (UK)
12.30 - 14.00
Innsbruck
Implementation and Real-World Practice of rtCGM in Remote Visits Before, During and After COVID-19
Keri Leone
Peter Adolfsson
Troels Krarup Hansen
19.15 - 20.15
Vienna
Industry Evening Symposia - Insulet
18.45 - 19.45
Innsbruck
Who benefits most from an early combination treatment approach in type 2 diabetes?
Matthias Blüher
18.45 - 19.45
Klagenfurt
Testosterone Treatment for men with hypogonadism and prediabetes/diabetes
Geoff Hacket
Gary Wittert
Sandeep Dhinsda
18.45 - 19.45
Villach
Metformin – the heart of the matter
G. Schernthaner
18.45 - 19.45 CET
Vienna
Improving CV risk management in patients with obesity
Registration Link
John Deanfield
18.45 - 19.45
Linz
Pioneering pathways for 2nd-generation basal insulin use: Advancing the conversation
18.45 - 20.15
Graz
Clinical Learnings from VERTIS CV for Patients with Diabetes and Cardiovascular Disease: A Cross Specialty Discussion
Chris Cannon (US)
Rich Pratley (US)
18.45 - 20.15 CET
Vienna
Exploring new paradigms in insulin therapy to improve outcomes
Registration Link
Stephen Gough (Denmark)
14.00 - 15.00
Vienna
Industry Afternoon Symposia - Tandem Diabetes Care
All Symposia

Industry "Meet-the-Expert"
Sessions at EASD 2020

Tuesday
Wednesday
Thursday
Friday
10.30 - 11.00 CEST
Enhancing patient care into the future
Melanie Davies (UK)
John Buse (USA)
11.30 - 12.00 CET
Cardiometabolic Collaboration: Current Reality and Challenges – and a Way Forward
Stephan Jacob
Matthew Cavender
13.00 - 13.30 CEST
Perspectives from different specialities on the joint clinical practice guidelines for the management of non-alcoholic fatty liver disease
Hannele Yki-Jarvinen (Finland)
Philip Newsome (UK)
14.00 - 14.30
New Learnings from the VERTIS CV Outcome Trial for Our Patients with Type 2 Diabetes and Cardiovascular Disease
Samuel Dagogo-Jack (US)
10.30 - 11.00
Severe metabolic syndrome based on a single missing hormone? Sharpen your eyes for lipodystrophy
Martin Wabitsch
11.30 - 12.00
Accelerating change with SGLT2 inhibitors to improve outcomes in T2D
Naresh Kanumilli (UK)
Francesco Giorgino (Italy)
13.00 - 13.30
The clinical and metabolic complexity of lipodystrophy, old challenges and new treatment opportunities
Giovanni Ceccarini
14.00 - 14.30 CET
Is basal-bolus still the go-to option for the uncontrolled T2D basal insulin patient?
Gurpreet Anand
Adie Viljoen
10.30 - 11.00
Diabeloop: where do we stand with the French closed-loop systems?
11.30 - 12.00
Introducing Lyumjev, a fast-acting insulin to improve glycemic control
Emma Wilmot (UK)
14.00-14.30
Ypsomed’s road to an individualised and smartphone-controlled therapy
James Mayjor (Australia)
15.00 - 15.30
Guardian™ Connect CGM: Predicting and Mitigating Glycemic Excursions in the Real-World
Robert Vigersky
10.30 - 11.00
Diabeloop: where do we stand with the French closed-loop systems?
11.30 - 12.00
Introducing Lyumjev, a fast-acting insulin to improve glycemic control
Emma Wilmot (UK)
14.00-14.30
Ypsomed’s road to an individualised and smartphone-controlled therapy
James Mayjor (Australia)
15.00 - 15.30
Guardian™ Connect CGM: Predicting and Mitigating Glycemic Excursions in the Real-World
Robert Vigersky
All MTE Sessions

Sponsors at EASD 2020

Search for Sponsors:
Search
Exhibition
Exhibition
All Sponsors

Hotel reservation for EASD 2021

The official housing bureau is INTERPLAN Congress, Meeting & Event Management AG.
Book your hotel in Stockholm

Hotel reservation for EASD 2022

The official housing bureau is INTERPLAN Congress, Meeting & Event Management AG.
Book your hotel in Madrid
Legal NoticeData Protection